Post-ERCP pancreatitis and its prevention (Q36666312)

15 August 2017

1 reference

title

Post-ERCP pancreatitis and its prevention (English)

1 reference

15 August 2017

Carl D Frank

1

1 reference

15 August 2017

Douglas G Adler

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Nature Reviews Gastroenterology & Hepatology

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

680-688

1 reference

Bedside scoring system to predict the risk of developing pancreatitis following ERCP.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Risk factors for complications after performance of ERCP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Endoscopic sphincterotomy complications and their management: an attempt at consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Hyperamylasemia after ERCP with ionic and non-ionic contrast media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Post-ERCP pancreatitis: reduction by routine antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Somatostatin and octreotide in acute pancreatitis: the never-ending story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

An assessment of the learning curve for precut biliary sphincterotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Prevention of post-ERCP pancreatitis: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Pancreatic-duct stent placement facilitates difficult common bile duct cannulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

A survey of physician practices on prophylactic pancreatic stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Improved stent characteristics for prophylaxis of post-ERCP pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

Risk factors for post-ERCP pancreatitis: a prospective, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Risk Factors for Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Complications of diagnostic and therapeutic ERCP: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Complications of endoscopic sphincterotomy: results from a single tertiary referral center

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Complications of endoscopic biliary sphincterotomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Changes in pancreatic exocrine secretion with age: pancreatic exocrine secretion does decrease in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Effect of nifedipine on sphincter of Oddi motor activity: studies in healthy volunteers and patients with biliary dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

A randomised, prospective study comparing two contrast media in ERCP

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995)

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in man

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

A simple way of avoiding post-ERCP pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0654

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0654

1 reference

Dimensions Publication ID

15 August 2017

1048995210

0 references

1 reference